DAE HWA PHARM CO., LTD
067080 | KO
Overview
Corporate Details
- ISIN(s):
- KR7067080002
- LEI:
- Country:
- South Korea
- Address:
- 강원도 횡성군 횡성읍 한우로 495, 횡성군
- Website:
- http://www.dhpharm.co.kr
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-19 00:00 |
Capital/Financing Update
주요사항보고서(교환사채권발행결정)
|
Korean | 34.5 KB | ||
| 2025-09-19 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
|
Korean | 31.8 KB | ||
| 2025-09-18 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.8 KB | ||
| 2025-08-20 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 158.8 KB | ||
| 2025-08-11 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.7 MB | ||
| 2025-08-06 00:00 |
Notice of Dividend Amount
현금ㆍ현물배당결정 (분기배당)
|
Korean | 8.3 KB | ||
| 2025-08-05 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-07-22 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 158.8 KB | ||
| 2025-06-12 00:00 |
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정
|
Korean | 5.4 KB | ||
| 2025-06-12 00:00 |
Related Party Transaction
[기재정정]타인에대한채무보증결정
|
Korean | 24.3 KB | ||
| 2025-06-12 00:00 |
Capital/Financing Update
[기재정정]타인에대한담보제공결정
|
Korean | 25.9 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.4 MB | ||
| 2025-04-29 00:00 |
Regulatory Filings
투자판단관련주요경영사항 (리포락셀액(파클리탁셀)의 품목허가사항 변경신청 (유방암 신규 적응증 추가를 위한 식품의약품안전…
|
Korean | 16.5 KB | ||
| 2025-04-23 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-04-23 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB |
Automate Your Workflow. Get a real-time feed of all DAE HWA PHARM CO., LTD filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for DAE HWA PHARM CO., LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DAE HWA PHARM CO., LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Leading producer of plasma-derived medicines for patients with rare and chronic diseases.
Spain
GRF
Spain
GRF
Develops & manufactures pharmaceuticals for cardiovascular, CNS, cancer, and diabetes globally.
Latvia
GRD1R
Latvia
GRD1R
Offers medical imaging solutions, from contrast agents to AI, for healthcare professionals.
France
GBT
France
GBT
South Korea
036180
Clinical-stage biopharma developing novel drugs for liver fibrosis and pneumoconiosis.
United States of America
GYRE
United States of America
GYRE
A global consumer healthcare leader providing trusted, science-backed OTC brands for everyday health.
United Kingdom
HLN
United Kingdom
HLN
A pharmaceutical manufacturer of finished medicines and plant-derived phytochemical substances.
Ukraine
GFARM
Ukraine
GFARM
Developing selective therapies for cancer and infections like bladder cancer and UTIs.
Sweden
HAMLET
Sweden
HAMLET
Develops innovative medicines for chronic diseases through antibody and small molecule research.
South Korea
009420
South Korea
009420
Pharmaceutical firm specializing in anesthetics and narcotic analgesics for global markets.
South Korea
293480
South Korea
293480